{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:17:33Z","timestamp":1788427053498,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.coi.2026.102820","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:14:35Z","timestamp":1784834075000},"page":"102820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cure for psoriasis \u2014 a prospective outlook"],"prefix":"10.1016","volume":"102","author":[{"given":"Siba P","family":"Raychaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti K","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102820_sbref1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.jid.2024.09.012","article-title":"Curing Psoriasis","volume":"144","author":"Lwin","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2026.102820_sbref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102702","article-title":"Is Psoriatic Arthritis a dissemination of cutaneous psoriatic TRM cells? Role of Tissue-resident memory T cells (TRM) in psoriatic disease","volume":"98","author":"Raychaudhuri","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2026.102820_sbref3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamadermatol.2025.1625","article-title":"Defining on-treatment remission in plaque psoriasis: a consensus statement from the National Psoriasis Foundation","volume":"161","author":"Armstrong","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S0190-9622(08)80242-3","article-title":"Onset of psoriasis in the tenth decade of life","volume":"27","author":"Raychaudhuri","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0190-9622(84)80103-6","article-title":"An appraisal of measures to prevent and control psoriasis","volume":"10","author":"Farber","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib6","first-page":"35","article-title":"Concept of total care: a third dimension in the treatment of psoriasis","volume":"59","author":"Farber","year":"1997","journal-title":"Cutis"},{"key":"10.1016\/j.coi.2026.102820_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102658","article-title":"Advances in treatment of psoriatic arthritis: current guidelines and emerging therapies","volume":"97","author":"Feldkamp","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2026.102820_sbref8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2026.102820_sbref9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2026.102820_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56719-8","article-title":"GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets","volume":"16","author":"Dand","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102820_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102820_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archdermatol.2009.73","article-title":"Psoriasis bench to bedside: genetics meets immunology","volume":"145","author":"Nair","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.det.2014.09.001","article-title":"Genetics of psoriasis","volume":"33","author":"Mahil","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.coi.2026.102820_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2026.102820_sbref15","doi-asserted-by":"crossref","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","article-title":"IL-17 receptor and its functional significance in psoriatic arthritis","volume":"359","author":"Raychaudhuri","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.coi.2026.102820_sbref17","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216658","article-title":"Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells","volume":"81","author":"Raychaudhuri","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102820_bib17","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jid.2021.01.005","article-title":"Differential changes in inflammatory mononuclear phagocyte and T-cell profiles within psoriatic skin during Treatment with Guselkumab vs. Secukinumab","volume":"141","author":"Mehta","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib18","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00332","article-title":"Tissue-resident T cells: dynamic players in skin immunity","volume":"5","author":"Mueller","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102820_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102820_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.coi.2026.102820_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2016.03.019","article-title":"A role for CCR5(+) CD4 T cells in cutaneous psoriasis and for CD103(+) CCR4(+) CD8 Teff cells in the associated systemic inflammation","volume":"70","author":"Sgambelluri","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2026.102820_bib23","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102820_bib24","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing alphabeta T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2026.102820_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory T H 17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci Immunol"},{"issue":"suppl 9","key":"10.1016\/j.coi.2026.102820_bib26","article-title":"Characterization of the tissue resident memorial T cells in autoimmune arthritis: a comparative study of psoriatic arthritis and rheumatoid arthritis [abstract]","volume":"76","author":"Raychaudhuri","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102820_bib27","unstructured":"Liu F., Shi H., Turner J.D., Anscombe R., Li J., Sekine T., Hammitzsch A., et al. CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue."},{"key":"10.1016\/j.coi.2026.102820_bib28","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.19236","article-title":"Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study","volume":"37","author":"Sch\u00e4kel","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2026.102820_bib29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.immuni.2015.11.008","article-title":"T-box transcription factors combine with the cytokines TGF-\u03b2 and IL-15 to control tissue-resident memory T cell fate","volume":"43","author":"L. Mackay","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2026.102820_bib30","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/nm.3962","article-title":"Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma","volume":"21","author":"Adachi","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102820_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102820_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2022.05.1011","article-title":"Tapinarof inhibits the formation, cytokine production, and persistence of resident memory Tcell in vitro","volume":"142","author":"Mooney","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaad.2022.06.1171","article-title":"One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: results from the PSOARING 3 trial","volume":"87","author":"Strober","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib34","article-title":"LB1703 high induction dosing of Risankizumab in patients with moderate-to-severe plaque psoriasis: interim results from the phase 2 KNOCKOUT study","volume":"143","author":"Blauvelt","year":"2023","journal-title":"J Invest Dermatol (Abstract)"},{"key":"10.1016\/j.coi.2026.102820_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: safety, efficacy, pharmacokinetics and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","volume":"136","author":"Krueger","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2026.102820_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2012.08.021","article-title":"Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation","volume":"68","author":"Kaffenberger","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.15","article-title":"Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion","volume":"5","author":"Li","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.coi.2026.102820_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bmt.1702703","article-title":"Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy","volume":"26","author":"Adkins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.coi.2026.102820_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.12026","article-title":"Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation","volume":"159","author":"Mori","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coi.2026.102820_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.20517","article-title":"The promise and challenges of cell therapy for psoriasis","volume":"185","author":"Lwin","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.coi.2026.102820_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-023-01883-6","article-title":"Lowdose interleukin-2 for psoriasis therapy based on the regulation of Th17\/Treg cell balance in peripheral blood","volume":"46","author":"Qiao","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.coi.2026.102820_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.300.6729.908","article-title":"Clearance of severe psoriasis after allogenic bone marrow transplantation","volume":"300","author":"Eedy","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2026.102820_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103687","article-title":"Harnessing the potential of CAR-T cell in lupus treatment: from theory to practice","volume":"23","author":"Alsuliman","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102820_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102820_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178213","article-title":"Psoriatic arthritis subtypes are phenocopied in humanized mic","volume":"9","author":"Ritchlin","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2026.102820_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/ced\/llag301","article-title":"Long-term remission of severe psoriasis following cd19 car-t cell therapy for follicular lymphoma","author":"Gulliver","year":"2026","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2026.102820_bib49","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2665-9913(23)00034-6","article-title":"Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study","volume":"5","author":"Singla","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102820_bib50","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaad.2024.06.106","article-title":"Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: a population-based analysis","volume":"91","author":"Strober","year":"2024","journal-title":"Am Acad Dermatol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279152600097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279152600097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:48:22Z","timestamp":1788425302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095279152600097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S095279152600097X"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102820","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cure for psoriasis \u2014 a prospective outlook","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102820"}}